Affiliation:
1. Department of Laboratory Medicine, Microbiology Section, Hinduja Hospital, Mumbai, Maharashtra, India
Abstract
Abstract
Accurate diagnosis and treatment of Tuberculosis (TB) continues to elude us. To overcome this, detection of Mycobacterium tuberculosis (MTB) and testing for drug resistance is of paramount importance. Globally, only one in three patients are bacteriologically confirmed and just one in five is diagnosed with a WHO endorsed molecular test, emphasising that diagnostic gaps continue to preclude patients from accessing care. Therefore, it is essential that newer and affordable technologies for the detection of MTB in low and middle income countries (LMICs) reach that last mile. In this review we discuss various recent technologies for detection of active TB disease, that have the possibility of being considered, or are already WHO endorsed.